CUPR

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) closed the 2026-09-15 session at $2.93, down 8.44% versus the previous close (-0.27). The stock opened at $3.10 and traded between $2.90 and $3.30 during that session. Session trading volume was 91K shares. The volume-weighted average price (VWAP) is $2.52.

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares has a market capitalization of $7.9 million. CUPR is listed on the XNAS exchange. The company employs approximately 10 people. The recorded listing date is 2025-04-10.

On this page you can find market CUPR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.